Skip to content
2000
Volume 16, Issue 1
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The landscape of cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumour growth has ended. A complex scenario where the molecular features of tumours seem to be the cornerstone of any therapy is now emerging. Here we provide an overview on the different approaches to cancer treatment. This review will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanims underpinning their efficacy. Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small molecules, antiangiogenics and viral therapy. We briefly elaborate, finally, on new biomarkers development and how it should rule and determine the future of therapeutic research in cancer.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161210789941847
2010-01-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161210789941847
Loading

  • Article Type:
    Research Article
Keyword(s): antiagiogenesis; biomarkers; Cancer therapy; chemotherapy; targeted therapy; virotherapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test